Gerald T. Keusch | Academic Influence

Gerald T. Keusch's AcademicInfluence.com Rankings

Gerald T. Keusch

Medical

#1381

World Rank

#1713

Historical Rank

#371

USA Rank

Public Health

#224

World Rank

#233

Historical Rank

#62

USA Rank

medical Degrees

Gerald T. Keusch

Philosophy

#5529

World Rank

#8356

Historical Rank

#1434

USA Rank

Logic

#2801

World Rank

#3844

Historical Rank

#627

USA Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Gerald T. Keusch's Degrees

Doctorate Medicine Harvard University

Why Is Gerald T. Keusch Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Gerald T. Keusch is an American physician-scientist and academic administrator. Keusch is the associate provost for global health at Boston University Medical Campus and a professor of international health and medicine at Boston University School of Public Health. He was the director of John E. Fogarty International Center and the associate director of international research at the National Institutes of Health from 1998 to 2003.

(See a Problem?)

Gerald T. Keusch's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. (2000) (562)
Infection and diabetes: the case for glucose control. (1982) (554)
Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. (1992) (424)
Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin- binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide (1986) (390)
The intolerable burden of malaria: a new look at the numbers. (2001) (360)
The history of nutrition: malnutrition, infection and immunity. (2003) (357)
Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. (2004) (293)
The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I. (1972) (291)
Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyroidectomy. (1995) (258)
Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli. (1987) (246)
Stigma and global health: developing a research agenda (2006) (240)
Environmental enteric dysfunction: pathogenesis, diagnosis, and clinical consequences. (2014) (217)
Health Innovation Networks to Help Developing Countries Address Neglected Diseases (2005) (209)
Shiga Toxins Stimulate Secretion of Interleukin-8 from Intestinal Epithelial Cells (1999) (196)
Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19 (2020) (190)
Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment. (1978) (185)
Nutrition and infection. (1986) (162)
Translocation of Shiga toxin across polarized intestinal cells in tissue culture (1996) (162)
Implications of Acquired Environmental Enteric Dysfunction for Growth and Stunting in Infants and Children Living in Low- and Middle-Income Countries (2013) (161)
Addressing the growing burden of trauma and injury in low- and middle-income countries. (2005) (157)
Epithelial cell invasion: an overlooked property of enteropathogenic Escherichia coli (EPEC) associated with the EPEC adherence factor. (1989) (156)
Construction and analysis of TnphoA mutants of enteropathogenic Escherichia coli unable to invade HEp-2 cells (1990) (156)
In Vivo Transduction with Shiga Toxin 1-Encoding Phage (1998) (153)
Regulation of the Shiga-like toxin II operon in Escherichia coli (1996) (143)
Sustaining Global Surveillance and Response to Emerging Zoonotic Diseases (2009) (143)
Zoonoses and marginalised infectious diseases of poverty: Where do we stand? (2011) (138)
Integrating Clinical Research into Epidemic Response: The Ebola Experience (2017) (129)
Erythropoietin in polycystic kidneys. (1989) (128)
Mediation of Cryptosporidium parvumInfection In Vitro by Mucin-Like Glycoproteins Defined by a Neutralizing Monoclonal Antibody (2000) (118)
The Origin of COVID-19 and Why It Matters (2020) (115)
Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies (1989) (115)
Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. (1998) (109)
Shiga Toxins 1 and 2 Translocate Differently across Polarized Intestinal Epithelial Cells (1999) (109)
In vitro encystation of Giardia lamblia: large-scale production of in vitro cysts and strain and clone differences in encystation efficiency. (1991) (105)
The Global Health System: Actors, Norms, and Expectations in Transition (2010) (102)
Thalassemia intermedia, with iron overload, cardiac failure, diabetes mellitus, hypopituitarism and porphyrinuria. (1967) (102)
Responses of Human Intestinal Microvascular Endothelial Cells to Shiga Toxins 1 and 2 and Pathogenesis of Hemorrhagic Colitis (1999) (100)
Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death (1994) (100)
Acquired lactose malabsorption in Thai children. (1969) (93)
Classification of enterotoxins on the basis of activity in cell culture. (1975) (91)
Trimethoprim-sulfamethoxazole in the United States. (1979) (89)
Pathogenesis of bacterial diarrheas. I. (1971) (89)
Relative influences of sex, race, environment, and HIV infection on body composition in adults. (1999) (88)
Lactase deficiency in Thailand: effect of prolonged lactose feeding. (1969) (86)
Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells. (1995) (84)
A comparison of HEp-2 cell invasion by enteropathogenic and enteroinvasive Escherichia coli. (1990) (83)
Interleukin‐1β (IL‐1β), IL‐1 receptor antagonist, and TNFα production in whole blood (1992) (81)
Dialysis-related amyloidosis revisited. (2005) (80)
Lectin activation in Giardia lamblia by host protease: a novel host-parasite interaction. (1986) (80)
Description and characterization of a surface lectin from Giardia lamblia (1986) (78)
Pathogenesis of shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for shigella toxin involved in the fluid secretory response of rabbit small intestine. (1988) (76)
Correlation of Increased Metabolic Activity, Resistance to Infection, Enhanced Phagocytosis, and Inhibition of Bacterial Growth by Macrophages from Listeria- and BCG-Infected Mice (1972) (73)
Mitomycin immunoblot colony assay for detection of Shiga-like toxin-producing Escherichia coli in fecal samples: comparison with DNA probes (1993) (73)
Identification of chitin as a structural component of Giardia cysts (1985) (73)
New challenges in studying nutrition-disease interactions in the developing world. (2008) (71)
Effects of bile and bile salts on growth and membrane lipid uptake by Giardia lamblia. Possible implications for pathogenesis of intestinal disease. (1985) (70)
The pathogenesis of shigella diarrhea. II. Enterotoxin-induced acute enteritis in the rabbit ileum. (1972) (69)
Complete amino acid sequence of Shigella toxin B-chain. A novel polypeptide containing 69 amino acids and one disulfide bridge. (1986) (69)
Mammalian bile promotes growth of Giardia lamblia in axenic culture. (1983) (67)
Evidence-based global health. (2004) (67)
The Global Health System: Lessons for a Stronger Institutional Framework (2010) (66)
Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. (1994) (65)
Quantitative microassay in cell culture for enterotoxin of Shigella dysenteriae. (1972) (65)
Identification and characterization of taglin, a mannose 6-phosphate binding, trypsin-activated lectin from Giardia lamblia. (1987) (64)
Darbepoetin alpha in lower-than-equimolar doses maintains haemoglobin levels in stable haemodialysis patients converting from epoetin alpha/beta. (2007) (63)
Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR (1996) (63)
Shigella infections. (2021) (63)
Shigella toxin(s): description and role in diarrhea and dysentery. (1981) (61)
A review of human immunodeficiency virus infection in India. (1994) (58)
Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration. (1996) (57)
Association of Pseudomonas cepacia with chronic granulomatous disease (1975) (57)
Biological implications of polyparasitism. (1982) (56)
Shigellosis: recent progress, persisting problems and research issues. (1989) (56)
Endocarditis caused by Lactobacillus plantarum. (1973) (56)
Group D streptococcal bacteremia, with emphasis on the incidence and presentation of infections due to Streptococcus bovis. (1973) (55)
Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies (2007) (55)
Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells. (1996) (54)
Imaging diagnosis of sclerosing peritonitis and relation of radiologic signs to the extent of the disease (1995) (54)
Synthetic peptides of Shiga toxin B subunit induce antibodies which neutralize its biological activity (1988) (53)
Childhood diarrhea in sub-Saharan Africa. (1998) (52)
Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock (1983) (52)
Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e (1995) (51)
Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro (1994) (50)
Health innovation in developing countries to address diseases of the poor (2005) (50)
Normal absorption in Thai subjects with non-specific jejunal abnormalities. (1967) (50)
Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells. (1989) (50)
Shiga toxin: purification, structure, and function. (1991) (49)
Pathogenesis of Shigella diarrhea: rabbit intestinal cell microvillus membrane binding site for Shigella toxin (1986) (49)
Enzyme-linked immunosorbent assay for Shiga toxin and Shiga-like toxin II using P1 glycoprotein from hydatid cysts. (1990) (49)
Biology of Giardia lamblia. Detection of N-acetyl-D-glucosamine as the only surface saccharide moiety and identification of two distinct subsets of trophozoites by lectin binding (1988) (48)
Cryptosporidia--who is at risk? (1995) (48)
Summary of a workshop on clindamycin colitis. (1976) (48)
Micronutrients and Susceptibility to Infection (1990) (47)
Nutritional implications of parasitic infections. (2009) (47)
Specific membrane receptors: pathogenetic and therapeutic implications in infectious diseases. (1979) (45)
Combining High Risk Science With Ambitious Social And Economic Goals (1999) (45)
Thrombotic thrombocytopenic purpura associated with Shiga toxins. (1997) (45)
Co-trimoxazole(Trimethoprim-sulfamethoxazole) (1982) (44)
Shiga toxin induces superoxide production in polymorphonuclear cells with subsequent impairment of phagocytosis and responsiveness to phorbol esters. (1999) (44)
Epidemiology of HIV and AIDS in India. (1994) (43)
Development of a Bacillus subtilis-Based Rotavirus Vaccine (2010) (43)
COMMITTEE ON ACHIEVING SUSTAINABLE GLOBAL CAPACITY FOR SURVEILLANCE AND RESPONSE TO EMERGING DISEASES OF ZOONOTIC ORIGIN (2009) (43)
Enzyme-linked immunosorbent assay for shigella toxin (1986) (43)
Malnutrition in AIDS. (1993) (42)
One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays. (1993) (41)
Pathogenesis of Shigella diarrhea. XVI. Selective targetting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport. (1989) (40)
Pathogenesis of shigella diarrhea. Serum anticytotoxin antibody response produced by toxigenic and nontoxigenic Shigella dysenteriae 1. (1976) (40)
Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients. (2006) (40)
Nutritional aspects of AIDS. (1990) (39)
Selective primary health care: strategies for control of disease in the developing world. XXIII. Control of infection to reduce the prevalence of infantile and childhood malnutrition. (1986) (38)
Intracellular bactericidal activity of leukocytes in whole blood for the diagnosis of chronic granulomatous disease of childhood. (1975) (38)
Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice. (2011) (37)
Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development (2021) (37)
Antibacterial functions of macrophages in experimental protein-calorie malnutrition. II. Cellular and humoral factors for chemotaxis, phagocytosis, and intracellular bactericidal activity. (1978) (37)
An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum. (1997) (37)
Nutritional effects on response of children in developing countries to respiratory tract pathogens: implications for vaccine development. (1991) (36)
Identification and partial purification of a lectin on the surface of the sporozoite of Cryptosporidium parvum. (1992) (36)
Catheter-related complications during continuous ambulatory peritoneal dialysis (CAPD): a retrospective study on sixty-two double-cuff Tenckhoff catheters. (1987) (35)
Axonally Transported Shigella Cytotoxin is Neuronotoxic (1985) (35)
Growth inhibition of the intestinal parasite Giardia lamblia by a dietary lectin is associated with arrest of the cell cycle. (1994) (35)
Vitamin A supplements--too good not to be true. (1990) (34)
Antimicrobial therapy for enteric infections and typhoid fever: state of the art. (1988) (34)
A monkey model for enterohemorrhagic Escherichia coli infection. (2001) (34)
Pathogenesis of Shigella diarrhea. 3. Effects of shigella enterotoxin in cell culture. (1973) (34)
Giardia lamblia: evaluation of roller bottle cultivation. (1982) (33)
Expression and purification of Shiga-like toxin II B subunits (1995) (32)
Enteric infection : mechanisms, manifestations, and management (1990) (32)
Irreversibility of cyclosporine-induced renal function impairment in heart transplant recipients. (1993) (32)
The Global Health System: Linking Knowledge with Action—Learning from Malaria (2010) (32)
Infectious Disease Threats: A Rebound To Resilience. (2021) (32)
Shiga toxin: intestinal cell receptors and pathophysiology of enterotoxic effects. (1991) (31)
Child Health and Survival: The UNICEF Gobi-Fff Program (1987) (31)
Opportunistic infections in colon carcinoma. (1974) (31)
Attachment of Cryptosporidium parvum sporozoites to human intestinal epithelial cells. (1998) (31)
Combination amphotericin B-rifampin therapy for pulmonary aspergillosis in a leukemic patient. (1976) (31)
Quantitation of the rabbit intestinal glycolipid receptor for Shiga toxin. Further evidence for the developmental regulation of globotriaosylceramide in microvillus membranes. (1989) (31)
Prevalence of enteric viruses among hospital patients with AIDS in Kinshasa, Zaire (1993) (30)
Cytomegalovirus disease of late onset following renal transplantation: a potentially fatal entity. (1994) (30)
Role of a Gal/GalNAc-specific sporozoite surface lectin in Cryptosporidium parvum-host cell interaction. (1994) (30)
Prognostic factors of hemolytic uremic syndrome in renal allografts. (1993) (30)
Treatment and prevention of travellers' diarrhoea (1992) (30)
Detection of Shiga-Like Toxin-Producing Escherichia coli in Ground Beef and Milk by Commercial Enzyme Immunoassay. (1996) (29)
Infant and child enteritis-malabsorption-malnutrition: the potential of limited studies with low-dose antibiotic feeding. (1974) (29)
Production and characterization of exotoxin(s) of Shigella dysenteriae type 1. (1975) (29)
An 88,000-Mr Giardia lamblia surface protein which is immunogenic in humans (1986) (29)
14C-Glucose Oxidation in Whole Blood: a Clinical Assay for Phagocyte Dysfunction (1972) (28)
Subclinical malabsorption in Thailand. I. Intestinal absorption in Thai children. (1972) (27)
Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C. (2010) (27)
Ectopic ACTH syndrome and medullary thyroid carcinoma. (1977) (26)
Host defense mechanisms in protein energy malnutrition. (1981) (25)
Transcellular permeability of capillaries in experimental cholera. (1969) (25)
Pathogenesis of shigella diarrhea: evidence for an N-linked glycoprotein shigella toxin receptor and receptor modulation by beta-galactosidase. (1986) (25)
Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets. (2012) (25)
Pathogenesis of bacterial diarrheas (second of two parts). (1971) (24)
What do -omics mean for the science and policy of the nutritional sciences? (2006) (24)
Nutrition and immunity: from A to Z. (2009) (24)
Immune function in the malnourished host. (1982) (23)
Subepidermal bullae secondary to Escherichia coli septicemia. (1974) (22)
Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems (1993) (22)
A vaccine against rotavirus--when is too much too much? (1997) (22)
Introduction: The Fogarty International Research Ethics Education and Curriculum Development Program in Historical Context (2013) (22)
Health research: Tapping the power of small institutions (2003) (22)
Attachment of Cryptosporidium parvumSporozoites to Human Intestinal Epithelial Cells (1998) (22)
Enteric Infection 2: Intestinal Helminths (1998) (21)
Hepatitis C RNA prevalence in a Western European organ donor pool and virus transmission by organ transplantation. (1994) (20)
Rigorous Clinical Trial Design in Public Health Emergencies Is Essential (2018) (20)
Antibacterial functions of macrophages in experimental protein-calorie malnutrition. I. Description of the model, morphologic observations, and macrophage surface IgG receptors. (1978) (20)
Shigella toxin and the pathogenesis of shigellosis. (2008) (20)
High prevalence in Switzerland of pure red-cell aplasia due to anti-erythropoietin antibodies in chronic dialysis patients: report of five cases. (2004) (19)
Kidney procurement from non-heartbeating donors: transplantation results. (1992) (19)
Stigma and global health: looking forward (2006) (19)
HeLa cell adherence and cytotoxin production by enteropathogenic Escherichia coli isolated from infants with diarrhea in Thailand (1987) (19)
Reduced Complications during Hemodialysis by Automatic Blood Volume Controlled Ultrafiltration (2007) (19)
Ecological control of the bacterial diarrheas: a scientific strategy. (1978) (18)
Letter: Staphylococcus aureus antigen in cerebrospinal fluid cross-reactive with Haemophilus influenzae type b antiserum. (1975) (17)
Immature Circulating Lymphocytes In Severely Malnourished Guatemalan Children (1987) (17)
Shiga toxin: production and purification. (1988) (17)
Proceedings of a workshop: Impact of infection on nutritional status of the host (1977) (17)
[22] Shiga toxin: Production and purification (1988) (17)
The multilateral initiative on malaria: past, present, and future. (2004) (16)
Protozoal gastrointestinal infections (1992) (16)
Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features (2010) (16)
[Hemolytic-uremic syndrome following kidney transplantation: prognostic factors]. (1994) (15)
THE SUSCEPTIBILITY OF BACTEROIDES TO THE PENICILLINS AND CEPHALOTHIN (1966) (15)
Values and moral experience in global health: Bridging the local and the global (2010) (15)
Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood. (1992) (15)
Role of opsonins in clinical response to granulocyte transfusion in granulocytopenic patients. (1982) (15)
Neomycin-induced malabsorption in a tropical population. (1970) (14)
The consequences of fever. (1977) (14)
Subclinical malabsorption in Thailand. II. Intestinal absorption in American military and Peace Corps personnel. (1972) (14)
Vitamin A deficiency: slow progress towards elimination. (2015) (14)
IgA nephropathy and hypercalcemia in Whipple's disease. (1993) (13)
Systemic Gastro-intestinal Infections: A Clinical Overview (2002) (13)
A Vascular Permeability Defect in Experimental Cholera (1967) (13)
The new age of global health governance holds promise (2010) (13)
Effects of acute endotoxemia and glucose administration on circulating leukocyte populations in normal and diabetic subjects. (1978) (13)
Clinical trials during epidemics (2017) (13)
Science, not speculation, is essential to determine how SARS-CoV-2 reached humans (2021) (13)
Pandemic origins and a One Health approach to preparedness and prevention: Solutions based on SARS-CoV-2 and other RNA viruses (2022) (13)
Biochemical effects of cholera enterotoxin: oxidative metabolism in the infant rabbit. (1970) (12)
Impairment of hemolytic complement activation by both classical and alternative pathways in serum from patients with kwashiorkor. (1984) (12)
Ethics of randomized trials in a public health emergency (2018) (12)
[The imaging diagnosis of sclerosing peritonitis (SP) following continuous ambulatory peritoneal dialysis (CAPD)]. (1992) (12)
Trimethoprim/Sulfamethoxazole: An Overview (1983) (11)
Malabsorption due to paromomycin. (1970) (11)
Serum opsonic activity in acute protein-energy malnutrition. (1981) (11)
Diarrhea and Nutrient Requirements (1983) (11)
Rise in intraocular pressure during haemodialysis in a patient with reduced outflow facility (2007) (11)
BOARD ON AGRICULTURE AND NATURAL RESOURCES (2009) (10)
Uncoupling of oxidative phosphorylation by purified staphylococcal alpha toxin. (1970) (10)
Performance characteristics of hemofilters with heparin surface coating: an experimental study. (1992) (10)
CGVD Workshop: Should Haemophilus influenzae type B conjugate vaccines be introduced into the EPI? (1992) (10)
RECEPTOR-MEDIATED ENDOCYTOSIS OF SHIGELLA CYTOTOXIN1 (1981) (10)
Antioxidants in infection. (1993) (10)
[33] Shiga toxin as inhibitor of protein synthesis (1988) (9)
Peritonitis during continuous ambulatory peritoneal dialysis: improving patient defense by type of buffer of dialysate? (1981) (9)
The interpretation and significance of the xylose tolerance test in the tropics. (1970) (9)
Hyperparathyroidism after kidney transplantation: a retrospective case controlled study (1991) (8)
Outcome in critically ill patients with acute renal failure treated by continuous hemofiltration. (1991) (8)
Withdrawal of steroids after cadaveric kidney allotransplantation on maintenance triple therapy. (1989) (8)
Appendicitis Perforata in CAPD Patients -Report of Two Cases (1985) (8)
Immune responses in parasitic diseases. Part A: general concepts. (1982) (8)
Uremic small-artery disease with medial calcification. A complication of chronic renal failure and benefit from parathyroidectomy (1995) (8)
Crystallization of the B chain of Shiga-like toxin I from Escherichia coli. (1991) (7)
A 20-year follow-up of cadaveric kidney allotransplantation. (1992) (7)
Kinetics of absorption of toxin of Vibrio cholerae. (1975) (7)
The shigella paradigm and colitis due to enterohaemorrhagic Escherichia coli. (1994) (7)
Torsades de pointes during low-dosage sotalol therapy in haemodialysis patients. (1996) (7)
Erythropoiese und Serumerythropoietinkonzentration vor und nach Nierenallotransplantation (1989) (6)
Bacterial diarrheas. (1973) (6)
Vitamin E and Respiratory Tract Infections in Elderly Nursing Home Residents (2017) (6)
Malnutrition, Infection, and Immune Function (2006) (6)
In search of global governance for research in epidemics (2017) (6)
[Cardiovascular diseases after kidney transplantation: an analysis of predisposing factors]. (1981) (6)
Tertiary hyperparathyroidism after cadaver-kidney transplantation. (1984) (6)
Correction of renal transplant artery stenosis: early and long-term results. (1984) (6)
[Are cephalosporins more active than penicillin G in poisoning with the deadly Amanita?]. (1988) (6)
Biochemical effects of cholera enterotoxin. II. Glucose metabolism in the intestine of the infant rabbit. (1971) (6)
The rediscovery of Shiga toxin and its role in clinical disease. (1998) (5)
Malnutrition and Infection (1979) (5)
Drivers of Zoonotic Diseases (2009) (5)
Radiometric screening test for chronic granulomatous disease. (1973) (5)
[Continued ambulatory peritoneal dialysis. Results and complications in 24 patients]. (1980) (5)
The Global Health System: Institutions in a Time of Transition (2010) (5)
Bacterial toxins as virulence factors: Shiga bacillus dysentery viewed as a toxinosis. (1977) (5)
Effects of various antisera on the morphology, phagocytic ability, and metabolism of guinea-pig peritoneal macrophages. (1972) (5)
Introduction to the Workshop (1982) (5)
[Severe electrolyte disorders during the therapy of heart failure with the therapy of heart failure with the ACE-inhibitor enalapril]. (1986) (5)
Synthetic peptides of Shiga toxin B-subunit induce antibodies which neutralize the biological activities of the toxin. (1986) (4)
Relative and interacting effects of sex, race, and environment upon body cell mass in healthy adults (1998) (4)
Shiga toxin as inhibitor of protein synthesis. (1988) (4)
Dissociation of immunoregulatory function of blood monocytes from maturational state and expression of interleukin-1 in humans chronically infected with Schistosoma mansoni. (1990) (4)
Impact of infection on nutritional status: résumé of the opening discussion (1977) (4)
Résumé of the discussion on "Prophylactic measures" (1978) (4)
[Kaposi's sarcoma following kidney transplantation: remission following reduction of immunosuppression and consequent HIV infection]. (1988) (4)
The Rediscovery of Shiga Toxin and Its Role in Human Illness (1997) (4)
The role of bacterial adherence in infection. (1982) (4)
[Metastatic pulmonary calcification in patients with chronic renal insufficiency]. (1985) (4)
Editorial Response: Shiga Toxin—Producing Escherichia coli Serotype OX3:H21 as a Cause of Hemolytic-Uremic Syndrome (1997) (4)
[Pharmacokinetics of phenytoin in continuous ambulatory peritoneal dialysis. 2 cases and brief review of the literature]. (1984) (4)
Antegrade pyelography, percutaneous nephrostomy and ureteral perfusion (Whitaker test) for the renal transplant recipient. (1985) (4)
OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A. (1988) (4)
[Intact function of a transplanted kidney 3 years after organ transplantation with primary oxalosis]. (1979) (4)
Fever. To be or not to be. (1976) (4)
A new micromethod for determination of interleukin-1 production from frozen human blood mononuclear cells. (1987) (4)
Occurrence of ceroid pigment without malabsorption in Thailand. (1968) (4)
Stimulation of gastrointestinal antibody to Shiga toxin by orogastric immunization in mice (1994) (3)
Successful pregnancy in advanced renal failure without dialysis (1989) (3)
Sustainable Financing for Global Disease Surveillance and Response (2009) (3)
Identification ofChitin asaStructural Component ofGiardia Cysts (1985) (3)
Shiga toxins. (2000) (3)
[Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome]. (1986) (3)
[Acute kidney failure in patients with multiple injuries]. (1984) (3)
Infection and cell metabolism. (1976) (3)
Persistent, fulminant watery diarrhea complicating chronic active hepatitis. (1972) (3)
Incentives for Disease Surveillance, Reporting, and Response (2009) (3)
Microorganisms, malabsorption, diarrhea and dysnutrition. (1985) (3)
Evidence of a receptor for shigella toxin on rabbit intestinal micro villus membranes (1984) (3)
Extraction and Purification of Lipids (2003) (3)
Effect of shiga toxin on NaCl transport in rat distal colon. (1999) (3)
I. ENTEROTOXIN PRODUCTION BY SHIGELLA DYSENTERIAE 1 (1972) (3)
Perspectives in Foodborne Illness (2013) (3)
The Epidemiology and Pathophysiology of Invasive Bacterial Diarrheas (1983) (3)
[Management of cardiac tamponade in uremic pericarditis]. (1986) (2)
Shigellosis control--a rosy future? (1977) (2)
Pathogenesis of Shigella Diarrhea . XIV . (2017) (2)
Homing in on interventions in the malnutrition-infection complex. (1980) (2)
Governance Challenges for Zoonotic Disease Surveillance, Reporting, and Response (2009) (2)
Ecology of the intestinal tract (1974) (2)
Selective destruction of vagal sensory neurons using Shigella cytotoxin. (1988) (2)
Tropical sprue in Thailand. Report of the first documented case. (1969) (2)
Recent advances in the study of diarrheogenic bacteria (1991) (2)
Malnutrition and the Thymus Gland (2020) (2)
Pathogenesis of bacterial diarrheas. Part 1. (1971) (2)
Effective interventions to reduce infection in malnourished populations. Proceedings of a symposium held on June 12--16, 1977 Port-au-Prince, Haiti. (1978) (2)
[Bone-marrow toxicity, lactic acidosis, and disseminated intravascular coagulation following phenformin medication]. (1974) (2)
Asymptomatic hepatitis in adults given gamma-globulin for prophylaxis. Clinical and laboratory features. (1969) (2)
[Plasma exchange in progressive lupus nephritis]. (1982) (2)
When You Reach a Fork in the Road, Take it: Science and Product Development as Linked Paths (2008) (2)
Clinical issues, Childhood illnesses, vaccinations and nutritional status. (2000) (2)
Nutrition , Immunity , and Infectious Diseases in Infants and Children An Overview (2006) (2)
Interleukin-lfl (IL-lfl), IL-i receptor antagonist, and TNFa production in whole blood (1992) (2)
Spreading effective AIDS care in poor countries. A commentary on the Partners-in-Health/Zanmi Lasante experience in Haiti. (2004) (2)
Growth of toxigenic Escherichia coli in oral rehydration solutions. (1984) (2)
Kidney procurement from non‐heartbeating donors: transplantation results (1992) (2)
Global health: lessons from Bayh-Dole. (2007) (2)
Recognition mechanisms in infectious disease. (1979) (2)
Micronutrients and immune functions . Cytokines and metabolism (1990) (2)
CAPD system Zurich--smart, safe and simple. (1983) (2)
The potential impact of nutritional change on the global burden of viral disease. (2009) (2)
Achieving an Effective Zoonotic Disease Surveillance System (2009) (2)
[Secondary decontamination: when are hemodialysis and hemoperfusion indicated?]. (1992) (1)
Economic valuations in global health (2010) (1)
[Treatment of chronic kidney failure in diabetes mellitus]. (1983) (1)
Interpretation of animal and human intervention trials. (2009) (1)
and Peace Corps personnel (1972) (1)
Models of Cooperation, Capacity Building, and the Future of Global Health (2010) (1)
[Spontaneous kidney rupture]. (1990) (1)
[Hemoperfusion with activated charcoal in the treatment of drug overdose. Clinical experiences with 20 patients]. (1980) (1)
Susceptibilities ofGram-Negative Bacteria toCombinations ofAntimicrobial Agents InVitro (1975) (1)
An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 – Authors' reply (2021) (1)
The National Institutes of Health agenda for international research in micronutrient nutrition and infection interactions. (2000) (1)
Impact of infection on nutritional status: r#{233}sum#{233} of the opening discussion1' 2 (1977) (1)
[Essential cryoglobulinemia with glomerulonephritis as a variant of the purpura-arthralgia-nephritis syndrome]. (1987) (1)
Failure of Cholera Enterotoxin to Alter Cyclic 3′, 5′- Adenosine Monophosphate-Mediated Responses in Toad Urinary Bladder (1972) (1)
DIARRHEAL diseases. (1948) (1)
Effect of pindolol and propranolol on plasma renin and aldosterone in patients with renal allograft. (1983) (1)
Spreading effective AIDS care in poor countries, thoughts on the Partners-in-Health/Zanmi Lasante experience in Haiti. (2004) (1)
[Thrombocytosis following pancreas transplantation]. (1989) (1)
Figure 19.3, [Cost-Effectiveness: Intervention at Birth through...]. (2006) (1)
Effective interventions to reduce infection in malnourished populations. Proceedings of a symposium held on June 12--16, 1977, Port-au-Prince, Haiti. (1978) (1)
The Chicken Soup Controversy (1975) (1)
[Ergometrically determined work capacity in chronic hemodialysis treatment]. (1984) (1)
Toxin-associated Gastro-intestinal Disease: A clinical Overview (2002) (1)
Why cholera may be important to doctors in the U.S. (1971) (1)
Evidence for a beneficial effect of plasma exchange in severe active lupus nephritis (1989) (1)
Thrombocytosis following segmental duct-occluded pancreatic transplantation. (1990) (1)
[Nephrolithiasis after intestinal bypass: successful treatment with a low-fat diet]. (1981) (1)
[Glomerular changes in reflux nephropathy]. (1983) (1)
Chapter 19 – Shigellosis (2006) (0)
Recommendations, Challenges, and Looking to the Future (2009) (0)
Reply to Jacob and Colebunders. (2018) (0)
Box 9.2, Biomarkers to Assess Environmental Enteric Dysfunction (2016) (0)
Antegrade Pyelography, Urodynamic Studies, and Percutaneous Nephrostomy Drainage for Evaluation of Decreased Renal Function in the Renal Allograft Recipient (1987) (0)
Antihelminthic Therapy in Community-Based Family Planning and Health Projects (2019) (0)
Colonic and inflammatory bowel diseases. (1975) (0)
Making the Case for Zoonotic Disease Surveillance (2009) (0)
1768 Purification and Characterization of Shigella Toxin (2003) (0)
[Hemoperfusion with activated charcoal in acute glutethimide poisoning]. (1984) (0)
Experimental bacterial and parasitic infections : proceedings of the Workshop on Experimental Bacterial and Parasitic Infections, June 11-13, 1982, Tammsvik Mansion, Sweden (1983) (0)
Résumé of the discussion on "Interventions: strategies for success" (1978) (0)
[Results of kidney transplantation in patients over 60 years of age]. (1992) (0)
Book Review Biomedical Globalization By Sergio Díaz-Briquets and Charles C. Cheney. 209 pp. New Brunswick, N.J., Transaction Publishers, 2002. $34.95. 0-7658-0104-3 (2003) (0)
Antibiotics for uncomplicated severe malnutrition. (2013) (0)
Bullae Due to Pressure-Reply (1975) (0)
Perspective Piece The Origin of COVID-19 and Why It Matters (2020) (0)
Subject Index Vol. 28, 1981 (2004) (0)
Yersinia Enterocolitica: Clinical Observations (2018) (0)
Interleukin-1 ( 3 ( IL-1 / 3 ) , IL-1 receptor antagonist , and TNFa production in whole blood (2017) (0)
In support of the US Centers for Disease Control and Prevention (2012) (0)
[Alveolar hemorrhage]. (1989) (0)
THE EFFECT OF BUTYRATE ON THE REGULATORY ENZYMES OF THE SHIGA TOXIN RECEPTOR IN HUMAN CULTURED INTESTINAL CELLS. • 727 (1996) (0)
Chapter 5 – Nutrition and Micronutrients in Tropical Infectious Diseases (2006) (0)
[Temporary peritoneal dialysis in the treatment of acute kidney failure]. (1983) (0)
Eating Yuppie Cuisine (1994) (0)
Surveillance and Response of Select Zoonotic Disease Outbreaks (2009) (0)
Box 9.3, Interventions for Diarrheal Diseases (2016) (0)
Subclinical malabsorption in Thai ’ and (2005) (0)
Role of infectious disease specialists in Third World infectious diseases problems. (1987) (0)
Take HEED--if not now, when? (2004) (0)
[Erythropoiesis and serum erythropoietin concentrations before and after kidney allotransplantation]. (1989) (0)
The complex biology of infection. (1981) (0)
Shigella, Infection and Immunity (1998) (0)
Diazoxide and labetalol in acute hypertension during haemodialysis (2004) (0)
Biochemical effects of cholera enterotoxin. 3. Intestinal protein synthesis in the infant rabbit. (1973) (0)
Global health, personal action. (2004) (0)
BOARD ON GLOBAL HEALTH (2009) (0)
VITAMIN E AND RESPIRATORY INFECTIONS AMONG ELDERLY NURSING HOME RESIDENTS: A RANDOMIZED CONTROLLED TRIAL** (2008) (0)
Summary and Recommendations (1982) (0)
Dietary Supplements, Botanicals, and Probiotics: Hope or Hype? (2001) (0)
Symposium on Vitamin A and Immunity (2008) (0)
Technology Transfer Issues in Biotechnology: The Future of Global Health Networks (2009) (0)
Novel Human Pathogen Species (2009) (0)
Malnutrition and AIDS in the Developing World (1997) (0)
Cytokines, Metabolism, and Nutrition: Overview (1992) (0)
Contributors (2012) (0)
Nutrition and infections. (1982) (0)
Figure 9.1, Regional Burden of Diarrhea, Ages 0–4 Years, 2010 (2016) (0)
Calcium transport during hypertonic CAPD exchanges. (1985) (0)
Circulating immune complexes before and after renal transplantation. (1984) (0)
Should global financing be the main priority for pandemic preparedness? – Authors' reply (2021) (0)
Superficial gastro-intestinal infections: A clinical overview (2002) (0)
[Continuous arteriovenous hemofiltration for the treatment of acute kidney failure]. (1985) (0)
PLASMA ENDOTOXIN, PLASMA AND STOOL PRO AND AND INFLAMMATORY CYTOKINES AND STOOL SHIGA TOXIN IN PATIENTS WITH SHIGELLOSIS (1998) (0)
Should experimental vaccines be used to contain epidemic cholera in the Americas? (1992) (0)
Preface (1990) (0)
Book Review Parasitic Diseases Fifth edition. By Dickson D. Despommier, Robert W. Gwadz, Peter J. Hotez, and Charles A. Knirsch. 363 pp., illustrated. New York, Apple Trees Productions, 2005. $69.95. 0-9700027-7-7 (2006) (0)
Global Health and Global Health Ethics: Values in global health governance (2011) (0)
Synthesis and Recommendations (2008) (0)
[Drug-induced kidney disorders]. (1982) (0)
Book Review Vaccines: Preventing Disease and Protecting Health (Scientific and Technical Publication No. 596.) Edited by Ciro A. de Quadros. 398 pp., illustrated. Washington, D.C., Pan American Health Organization, 2004. $62. 92-75-11596-6 (2005) (0)
Study week on the interaction of parasitic diseases and nutrition, October 22-26, 1985 : summary (1986) (0)
Molecular Pathogenesis of Giardia lamblia: Adherence and Encystation (1991) (0)
Box 9.1, Major Interventions in Diarrheal Disease (2016) (0)
Less problems with hypotension-prone hemodialysis patients by blood volume control (2005) (0)
Figure 9.2, Regional Burden of Severe Diarrhea Episodes, Ages 0–4 Years, 2010 (2016) (0)
Public Committee Meeting Agendas (2009) (0)
Table 9.1, Cost-Effectiveness and Unit Cost of Interventions for Diarrheal Diseases (2016) (0)
Diarrheal Diseases Definitions and Classification (2015) (0)
DRUG-RELATED GASTRO-INTESTINAL SIDE EFFECTS OF IMPDH INHIBITORS - DOES ENTERIC COATED MYCOPHENOLATE SODIUM OFFER ANY BENEFIT? (2004) (0)
[Controlling bacterial ecology in infectious diarrhea: a logical strategy]. (1982) (0)
well-known LT or ST toxins and since a mutant strain of V. cholerae deleted of the gene for the production of the ADP-ribosyl transferase enzyme subunit A of cholera toxin (12) causes diarrhea in humans, the shigella (or Shiga-like) toxin (2003) (0)
Synthetic Peptides ofShiga ToxinB Subunit InduceAntibodies WhichNeutralize ItsBiological Activity (1988) (0)
Economic development, human development, and the pursuit of happiness, April 1, 2, and 3, 2004 (2008) (0)
[Treatment of uremic sympathicopathy with levodopa]. (1977) (0)
FIGURE 4-1, [The cycle of elements comprising an effective infectious disease surveillance system.]. (2009) (0)
Looking ahead: forecasting and planning for the longer-range future, April 1, 2, and 3, 2005 (2008) (0)
CHAPTER 18 – Shigellosis (2011) (0)
Reply (1995) (0)
Comparison of body composition in healthy African, African-American and Caucasian-American men and women (1995) (0)
which is immunogenic in humans. An 88,000-Mr Giardia lamblia surface protein (2013) (0)
[Creatinine of 250 micro mol/l: what should be done?]. (1997) (0)
[Circulating immune complexes before and after kidney allotransplantation]. (1984) (0)
treatment of resistant hypertension following renal transplantation with an angiotensin-converting-enzyme inhibitor (1990) (0)
Year Book of Infectious Diseases, 1993. (1990) (0)
Nutritional Needs and Assessment of Normal Growth. Based on an International Workshop Held in Rome, Italy, May 30-June 1, 1983.Michael Gracey , Frank Falkner (1986) (0)
Figure 9.3, Regional Burden of Diarrhea Mortality, Ages 0–4 Years, 2015 (2016) (0)
[Long-term course following kidney transplantation]. (1994) (0)
Program development for interventions in the nutrition-infection complex (1978) (0)
Addendum to article [22] (1988) (0)
Malaria. (2005) (0)

This paper list is powered by the following services:

Other Resources About Gerald T. Keusch

en.wikipedia.org

What Schools Are Affiliated With Gerald T. Keusch?

Gerald T. Keusch is affiliated with the following schools:

Image Attributions

Image Source for Gerald T. Keusch